Build Your Comparison

Side-by-side financial analysis
HNGE logo
HNGE
UNH logo
UNH
Try popular comparisons:

Stock Comparison

HNGE vs UNH

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
HNGE
Hinge Health, Inc.

Medical - Healthcare Information Services

HealthcareNYSE • US
Market Cap$5.15B
5Y Perf.+68.2%
UNH
UnitedHealth Group Incorporated

Medical - Healthcare Plans

HealthcareNYSE • US
Market Cap$370.80B
5Y Perf.+35.3%

HNGE vs UNH — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
HNGE logoHNGE
UNH logoUNH
IndustryMedical - Healthcare Information ServicesMedical - Healthcare Plans
Market Cap$5.15B$370.80B
Revenue (TTM)$646M$449.71B
Net Income (TTM)$-510M$12.04B
Gross Margin80.8%18.8%
Operating Margin-81.6%4.2%
Forward P/E26.0x22.2x
Total Debt$8M$78.39B
Cash & Equiv.$208M$24.36B

HNGE vs UNHLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

HNGE
UNH
StockMay 25Jun 26Return
Hinge Health, Inc. (HNGE)100168.2+68.2%
UnitedHealth Group … (UNH)100135.3+35.3%

Price return only. Dividends and distributions are not included.

Quick Verdict: HNGE vs UNH

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: UNH leads in 5 of 7 categories, making it the strongest pick for valuation and capital efficiency and profitability and margin quality. Hinge Health, Inc. is the stronger pick specifically for growth and revenue expansion and recent price momentum and sentiment. As sector peers, any of these can serve as alternatives in the same allocation.
🥇UNH emerged as the overall leader. Track its performance:
HNGE
Hinge Health, Inc.
The Growth Play

HNGE is the clearest fit if your priority is growth exposure and sleep-well-at-night.

  • Rev growth 50.6%, EPS growth -33.6%
  • Lower volatility, beta 1.32, Low D/E 2.1%, current ratio 1.47x
  • 50.6% revenue growth vs UNH's 11.8%
Best for: growth exposure and sleep-well-at-night
UNH
UnitedHealth Group Incorporated
The Insurance Pick

UNH carries the broadest edge in this set and is the clearest fit for income & stability and long-term compounding.

  • Dividend streak 16 yrs, beta 0.61, yield 2.1%
  • 236.1% 10Y total return vs HNGE's 74.0%
  • Beta 0.61, yield 2.1%, current ratio 0.79x
Best for: income & stability and long-term compounding
See the full category breakdown
CategoryWinnerWhy
GrowthHNGE logoHNGE50.6% revenue growth vs UNH's 11.8%
ValueUNH logoUNHLower P/E (22.2x vs 26.0x)
Quality / MarginsUNH logoUNH2.7% margin vs HNGE's -78.9%
Stability / SafetyUNH logoUNHBeta 0.61 vs HNGE's 1.32
DividendsUNH logoUNH2.1% yield; 16-year raise streak; the other pay no meaningful dividend
Momentum (1Y)HNGE logoHNGE+86.6% vs UNH's +31.0%
Efficiency (ROA)UNH logoUNH3.9% ROA vs HNGE's -69.5%, ROIC 9.2% vs -268.2%

HNGE vs UNH — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

Discover the Biotech & Healthcare Stocks Theme

These companies are key players in the Biotech & Healthcare Stocks ecosystem. See how they stack up against the rest of the sector.

Explore Theme
HNGEHinge Health, Inc.
FY 2025
Reportable Segment
100.0%$588M
UNHUnitedHealth Group Incorporated
FY 2025
Unitedhealthcare
94.4%$332.4B
Optumhealth
5.6%$19.8B

HNGE vs UNH — Financial Metrics

Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLUNHLAGGINGHNGE

Income & Cash Flow (Last 12 Months)

Evenly matched — HNGE and UNH each lead in 3 of 6 comparable metrics.

UNH is the larger business by revenue, generating $449.7B annually — 695.8x HNGE's $646M. UNH is the more profitable business, keeping 2.7% of every revenue dollar as net income compared to HNGE's -78.9%. On growth, HNGE holds the edge at +47.2% YoY revenue growth, suggesting stronger near-term business momentum.

MetricHNGE logoHNGEHinge Health, Inc.UNH logoUNHUnitedHealth Grou…
RevenueTrailing 12 months$646M$449.7B
EBITDAEarnings before interest/tax-$524M$23.2B
Net IncomeAfter-tax profit-$510M$12.0B
Free Cash FlowCash after capex$206M$19.7B
Gross MarginGross profit ÷ Revenue+80.8%+18.8%
Operating MarginEBIT ÷ Revenue-81.6%+4.2%
Net MarginNet income ÷ Revenue-78.9%+2.7%
FCF MarginFCF ÷ Revenue+31.9%+4.4%
Rev. Growth (YoY)Latest quarter vs prior year+47.2%+2.0%
EPS Growth (YoY)Latest quarter vs prior year-73.5%+0.7%
Evenly matched — HNGE and UNH each lead in 3 of 6 comparable metrics.

Valuation Metrics

UNH leads this category, winning 4 of 5 comparable metrics.
MetricHNGE logoHNGEHinge Health, Inc.UNH logoUNHUnitedHealth Grou…
Market CapShares × price$5.1B$370.8B
Enterprise ValueMkt cap + debt − cash$4.9B$424.8B
Trailing P/EPrice ÷ TTM EPS-12.59x30.88x
Forward P/EPrice ÷ next-FY EPS est.25.96x22.21x
PEG RatioP/E ÷ EPS growth rate
EV / EBITDAEnterprise value multiple18.21x
Price / SalesMarket cap ÷ Revenue8.75x0.83x
Price / BookPrice ÷ Book value/share14.10x3.66x
Price / FCFMarket cap ÷ FCF30.14x23.07x
UNH leads this category, winning 4 of 5 comparable metrics.

Profitability & Efficiency

UNH leads this category, winning 5 of 8 comparable metrics.

UNH delivers a 11.5% return on equity — every $100 of shareholder capital generates $12 in annual profit, vs $-139 for HNGE. HNGE carries lower financial leverage with a 0.02x debt-to-equity ratio, signaling a more conservative balance sheet compared to UNH's 0.77x. On the Piotroski fundamental quality scale (0–9), UNH scores 6/9 vs HNGE's 5/9, reflecting solid financial health.

MetricHNGE logoHNGEHinge Health, Inc.UNH logoUNHUnitedHealth Grou…
ROE (TTM)Return on equity-138.7%+11.5%
ROA (TTM)Return on assets-69.5%+3.9%
ROICReturn on invested capital-2.7%+9.2%
ROCEReturn on capital employed-135.5%+9.7%
Piotroski ScoreFundamental quality 0–956
Debt / EquityFinancial leverage0.02x0.77x
Net DebtTotal debt minus cash-$200M$54.0B
Cash & Equiv.Liquid assets$208M$24.4B
Total DebtShort + long-term debt$8M$78.4B
Interest CoverageEBIT ÷ Interest expense4.71x
UNH leads this category, winning 5 of 8 comparable metrics.

Total Returns (Dividends Reinvested)

HNGE leads this category, winning 5 of 6 comparable metrics.

A $10,000 investment in HNGE five years ago would be worth $17,396 today (with dividends reinvested), compared to $11,165 for UNH. Over the past 12 months, HNGE leads with a +86.6% total return vs UNH's +31.0%. The 3-year compound annual growth rate (CAGR) favors HNGE at 20.3% vs UNH's -4.2% — a key indicator of consistent wealth creation.

MetricHNGE logoHNGEHinge Health, Inc.UNH logoUNHUnitedHealth Grou…
YTD ReturnYear-to-date+43.4%+22.1%
1-Year ReturnPast 12 months+86.6%+31.0%
3-Year ReturnCumulative with dividends+74.0%-12.0%
5-Year ReturnCumulative with dividends+74.0%+11.7%
10-Year ReturnCumulative with dividends+74.0%+236.1%
CAGR (3Y)Annualised 3-year return+20.3%-4.2%
HNGE leads this category, winning 5 of 6 comparable metrics.

Risk & Volatility

UNH leads this category, winning 2 of 2 comparable metrics.

UNH is the less volatile stock with a 0.61 beta — it tends to amplify market swings less than HNGE's 1.32 beta. A beta below 1.0 means the stock typically moves less than the S&P 500.

MetricHNGE logoHNGEHinge Health, Inc.UNH logoUNHUnitedHealth Grou…
Beta (5Y)Sensitivity to S&P 5001.32x0.61x
52-Week HighHighest price in past year$66.90$415.96
52-Week LowLowest price in past year$30.08$234.60
% of 52W HighCurrent price vs 52-week peak+97.7%+98.2%
RSI (14)Momentum oscillator 0–10073.366.5
Avg Volume (50D)Average daily shares traded1.3M7.2M
UNH leads this category, winning 2 of 2 comparable metrics.

Analyst Outlook

Insufficient data to determine a leader in this category.

Wall Street rates HNGE as "Buy" and UNH as "Buy". Consensus price targets imply 13.5% upside for HNGE (target: $74) vs 2.4% for UNH (target: $419). UNH is the only dividend payer here at 2.13% yield — a key consideration for income-focused portfolios.

MetricHNGE logoHNGEHinge Health, Inc.UNH logoUNHUnitedHealth Grou…
Analyst RatingConsensus buy/hold/sellBuyBuy
Price TargetConsensus 12-month target$74.18$418.50
# AnalystsCovering analysts1452
Dividend YieldAnnual dividend ÷ price+2.1%
Dividend StreakConsecutive years of raises16
Dividend / ShareAnnual DPS$8.70
Buyback YieldShare repurchases ÷ mkt cap+1.3%+1.5%
Insufficient data to determine a leader in this category.
Key Takeaway

UNH leads in 3 of 6 categories (Valuation Metrics, Profitability & Efficiency). HNGE leads in 1 (Total Returns). 1 tied.

Best OverallUnitedHealth Group Incorpor… (UNH)Leads 3 of 6 categories
Loading custom metrics...

HNGE vs UNH: Frequently Asked Questions

10 questions · data-driven answers · updated daily

01

Is HNGE or UNH a better buy right now?

For growth investors, Hinge Health, Inc.

(HNGE) is the stronger pick with 50. 6% revenue growth year-over-year, versus 11. 8% for UnitedHealth Group Incorporated (UNH). UnitedHealth Group Incorporated (UNH) offers the better valuation at 30. 9x trailing P/E (22. 2x forward), making it the more compelling value choice. Analysts rate Hinge Health, Inc. (HNGE) a "Buy" — based on 14 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which has the better valuation — HNGE or UNH?

On forward P/E, UnitedHealth Group Incorporated is actually cheaper at 22.

2x.

03

Which is the better long-term investment — HNGE or UNH?

Over the past 5 years, Hinge Health, Inc.

(HNGE) delivered a total return of +74. 0%, compared to +11. 7% for UnitedHealth Group Incorporated (UNH). Over 10 years, the gap is even starker: UNH returned +236. 1% versus HNGE's +74. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

04

Which is safer — HNGE or UNH?

By beta (market sensitivity over 5 years), UnitedHealth Group Incorporated (UNH) is the lower-risk stock at 0.

61β versus Hinge Health, Inc. 's 1. 32β — meaning HNGE is approximately 116% more volatile than UNH relative to the S&P 500. On balance sheet safety, Hinge Health, Inc. (HNGE) carries a lower debt/equity ratio of 2% versus 77% for UnitedHealth Group Incorporated — giving it more financial flexibility in a downturn.

05

Which is growing faster — HNGE or UNH?

By revenue growth (latest reported year), Hinge Health, Inc.

(HNGE) is pulling ahead at 50. 6% versus 11. 8% for UnitedHealth Group Incorporated (UNH). On earnings-per-share growth, the picture is similar: UnitedHealth Group Incorporated grew EPS -14. 7% year-over-year, compared to -33. 6% for Hinge Health, Inc.. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

06

Which has better profit margins — HNGE or UNH?

UnitedHealth Group Incorporated (UNH) is the more profitable company, earning 2.

7% net margin versus -89. 9% for Hinge Health, Inc. — meaning it keeps 2. 7% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: UNH leads at 4. 2% versus -92. 9% for HNGE. At the gross margin level — before operating expenses — HNGE leads at 79. 6%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

07

Is HNGE or UNH more undervalued right now?

On forward earnings alone, UnitedHealth Group Incorporated (UNH) trades at 22.

2x forward P/E versus 26. 0x for Hinge Health, Inc. — 3. 7x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for HNGE: 13. 5% to $74. 18.

08

Which pays a better dividend — HNGE or UNH?

In this comparison, UNH (2.

1% yield) pays a dividend. HNGE does not pay a meaningful dividend and should not be held primarily for income.

09

Is HNGE or UNH better for a retirement portfolio?

For long-horizon retirement investors, UnitedHealth Group Incorporated (UNH) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.

61), 2. 1% yield, +236. 1% 10Y return). Both have compounded well over 10 years (UNH: +236. 1%, HNGE: +74. 0%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

10

What are the main differences between HNGE and UNH?

Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

In terms of investment character: HNGE is a small-cap high-growth stock; UNH is a large-cap quality compounder stock. UNH pays a dividend while HNGE does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.